Kolexia
Huart Antoine Néphrologie
Huart Antoine
Néphrologie
Hôpital Rangueil
Toulouse, France
155 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Vascularite Amyloïdose Vascularites associées aux anticorps anti-cytoplasme des neutrophiles Amylose à chaine légère d'immunoglobuline Cryoglobulinémie Polyangéite microscopique Vascularite systémique Granulomatose avec polyangéite Glomérulonéphrite

Collaborateurs

Voir plus
Chauveau Dominique
Chauveau Dominique
Hôpital Rangueil, Toulouse, France
Faguer Stanislas
Faguer Stanislas
Hôpital Rangueil, Toulouse, France
Ribes David
Ribes David
Hôpital Rangueil, Toulouse, France
Pugnet Gregory
Pugnet Gregory
Hôpital Purpan, Toulouse, France

Industries

Voir plus
B3TSI
40 collaboration(s)
Dernière en 2023
M3 Global Research Ltd
13 collaboration(s)
Dernière en 2023
PASCALEO
12 collaboration(s)
Dernière en 2023
A+A
10 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
IsAMYP: A Phase 2, Open Label, Multicenter, Single-stage Study to Evaluate the Efficacy of Isatuximab Plus Pomalidomide and Dexamethasone (IPd), in Patients With AL Amyloidosis Not in VGPR or Better After Any Previous Therapy
Essai Clinique (BMS)   05 mars 2024
A Study to Evaluate the Efficacy and Safety of Daratumumab in Combination With Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared to CyBorD Alone in Newly Diagnosed Systemic Amyloid Light-chain (AL) Amyloidosis: A Randomized Phase 3 Study to Evaluate the Efficacy and Safety of Daratumumab in Combination With Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared to CyBorD Alone in Newly Diagnosed Systemic AL Amyloidosis
Essai Clinique (Janssen)   27 février 2024
Towards etiological treatments in cardiomyopathies.
Presse medicale (Paris, France : 1983)   02 février 2024
Teclistamab in relapsed or refractory AL amyloidosis, a multinational retrospective case series.
Blood   14 décembre 2023
Digital Ischemia as a Rare Manifestation of C3 Glomerulopathy Associated With Monoclonal Gammopathy
Kidney international reports   13 décembre 2023
Efficacy and Safety of Daratumumab Monotherapy in Newly Diagnosed Patients with Stage 3B Light-Chain Amyloidosis: A Phase 2 Study By the European Myeloma Network
65th ASH Annual Meeting Abstracts   02 novembre 2023
Rituximab as maintenance therapy for ANCA-associated vasculitides: pooled analysis and long-term outcome of 277 patients included in the MAINRITSAN trials.
Annals of the rheumatic diseases   02 novembre 2023
Teclistamab in Relapsed Refractory Multiple Myeloma Patients on Dialysis: A French Experience
65th ASH Annual Meeting Abstracts   02 novembre 2023
Birtamimab: a new amyloidosis treatment?
Blood   06 octobre 2023
Real-world study of the efficacy and safety of belantamab mafodotin (GSK2857916) in relapsed or refractory multiple myeloma based on data from the nominative ATU in France: the IFM 2020-04 study.
Haematologica   01 octobre 2023